¹⁵O-Water Demonstrations at EANM’23:

When The Annual European Association of Nuclear Medicine Congress opens in Vienna on September 9, 2023, MedTrace is on the spot and ready to showcase its technology and present the latest from its ongoing Phase 3 Clinical Trial RAPID-WATER-FLOW.

At booth # 206, visitors can expect demonstrations of the MedTrace technology under development and available for investigational research:

• Experience the daily preparation of MedTrace’s automated 15O-water manufacturing system (P3 MT-100) when superuser Nanna Elgaard Toft, Biomedical Laboratory Scientist at Aarhus University Hospital, demonstrates how she prepares the system for a PET scan. Nanna Elgaard Toft has been working with MedTrace’s technology for more than two years and she is a part of the team at Aarhus University Hospital that has now scanned more than 3,000 patients using MedTrace’s P3 MT-100.

  15-minute demonstration sessions are running at:

  Sunday, September 10 at 13.15
  Sunday, September 10 at 14.30
  Monday, September 11 at 13.15
  Monday, September 11 at 14.30

  Limited spots are available. Reach out in advance to secure a demonstration.

  Aarhus University Hospital is using 15O-water PET undera permission for magistral preparation and a temporary exemption from CE-marking of the MedTrace Patient Kit granted by the Danish Medicines Agency.

• Get a close-up look at the aQuant software that is being developed to provide a fully automated analysis of quantitative MBF using 15O-water, with user input only required for confirmation and quality control.

• Receive a presentation of MedTrace’s Phase 3 Clinical Trial that seeks to evaluate the diagnostic accuracy and safety of 15O-water as a myocardial perfusion PET imaging agent in the diagnosis of CAD. The MedTrace Clinical Affairs Team will also share the latest on 15O-water research findings from around the globe.